WO2000063379A3 - The p2x3 receptor, methods of altering p2x3 receptor activity and uses thereof - Google Patents
The p2x3 receptor, methods of altering p2x3 receptor activity and uses thereof Download PDFInfo
- Publication number
- WO2000063379A3 WO2000063379A3 PCT/US2000/010919 US0010919W WO0063379A3 WO 2000063379 A3 WO2000063379 A3 WO 2000063379A3 US 0010919 W US0010919 W US 0010919W WO 0063379 A3 WO0063379 A3 WO 0063379A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- receptor
- methods
- altering
- activity
- receptor activity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002370659A CA2370659A1 (en) | 1999-04-21 | 2000-04-21 | The p2x3 receptor, methods of altering p2x3 receptor activity and uses thereof |
EP00926289A EP1180141A2 (en) | 1999-04-21 | 2000-04-21 | The p2x 3 receptor, methods of altering p2x 3receptor activity and uses thereof |
JP2000612458A JP2004500021A (en) | 1999-04-21 | 2000-04-21 | P2X3 receptor, method of altering P2X3 receptor activity and uses thereof |
MXPA01010646A MXPA01010646A (en) | 1999-04-21 | 2000-04-21 | The p2x3. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13033999P | 1999-04-21 | 1999-04-21 | |
US60/130,339 | 1999-04-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000063379A2 WO2000063379A2 (en) | 2000-10-26 |
WO2000063379A3 true WO2000063379A3 (en) | 2001-11-15 |
Family
ID=22444222
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/010919 WO2000063379A2 (en) | 1999-04-21 | 2000-04-21 | The p2x3 receptor, methods of altering p2x3 receptor activity and uses thereof |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1180141A2 (en) |
JP (1) | JP2004500021A (en) |
CA (1) | CA2370659A1 (en) |
MX (1) | MXPA01010646A (en) |
WO (1) | WO2000063379A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2006281497B2 (en) | 2005-08-15 | 2012-06-07 | F. Hoffmann-La Roche Ag | Piperidine and piperazine derivatives as P2X3 antagonists |
WO2007041087A2 (en) * | 2005-09-30 | 2007-04-12 | Merck & Co., Inc. | Nucleic acids encoding a functional mammalian purinoreceptor, p2x3, methods of production and use thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999036539A1 (en) * | 1998-01-16 | 1999-07-22 | Abbott Laboratories | Nucleic acids encoding a functional human purinoreceptor p2x3 and methods of production and use thereof |
-
2000
- 2000-04-21 MX MXPA01010646A patent/MXPA01010646A/en unknown
- 2000-04-21 CA CA002370659A patent/CA2370659A1/en not_active Abandoned
- 2000-04-21 WO PCT/US2000/010919 patent/WO2000063379A2/en not_active Application Discontinuation
- 2000-04-21 EP EP00926289A patent/EP1180141A2/en not_active Withdrawn
- 2000-04-21 JP JP2000612458A patent/JP2004500021A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999036539A1 (en) * | 1998-01-16 | 1999-07-22 | Abbott Laboratories | Nucleic acids encoding a functional human purinoreceptor p2x3 and methods of production and use thereof |
Non-Patent Citations (9)
Title |
---|
ALEXANDER, K. ET AL.: "Allosteric Modulation and Accelerated Resensitization of Human P2X3 Receptors by Cibacron Blue", JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, vol. 291, no. 3, December 1999 (1999-12-01), pages 1135 - 1142, XP002168399 * |
ALEXANDER, K. ET AL.: "Potentiation of ATP-gated human recombinant P2X3 receptor responses by cibacron blue", SOCIETY FOR NEUROSCIENCE ABSTRACTS, vol. 24, no. 1-2, 1998, pages 1601, XP000926456 * |
COOK, S.P. ET AL.: "A Memory for Extracellular Ca2+ by Speeding Recovery of P2X Receptors from Desensitization", JOURNAL OF NEUROSCIENCE, vol. 18, no. 22, 15 November 1998 (1998-11-15), pages 9238 - 9244, XP002168398 * |
GARCIA-GUZMAN, M. ET AL.: "Molecular characterization and pharmacological properties of the human P2X3 purinoceptor", MOLECULAR BRAIN RESEARCH, vol. 47, no. 1-2, July 1997 (1997-07-01), pages 59 - 66, XP002105595 * |
MILLER, K.J. ET AL.: "Cibacron blue allosterically modulates the rat P2X4 receptor", SOCIETY FOR NEUROSCIENCE ABSTRACTS, vol. 37, no. 12, December 1998 (1998-12-01), pages 1579 - 1586, XP000926481 * |
SAWYNOK, J. & REID, A.: "Peripheral adenosine 5'-triphosphate enhances nociception in the formalin test via activation of a purinergic P2X recptor", EUROPEAN JOURNAL OF PHARMACOLOGY, vol. 330, no. 2-3, 9 July 1997 (1997-07-09), pages 115 - 121, XP000926136 * |
TSUDA, M. ET AL.: "Evidence for the involvement of spinal endogenous ATP and P2X receptors in nociceptive responses caused by formalin and capsaicin in mice", BRITISH JOURNAL OF PHARMACOLOGY, vol. 128, no. 7, December 1999 (1999-12-01), pages 1497 - 1504, XP000926133 * |
UENO, S. ET AL.: "Cell type-specific ATP-activated responses in rat dorsal root ganglion neurons", BRITISH JOURNAL OF PHARMACOLOGY, vol. 126, no. 2, January 1999 (1999-01-01), pages 429 - 436, XP000926134 * |
VIRGINIO, C. ET AL.: "Trinitrophenyl-Substituted Nucleotides Are Potent Antagonists Selective for P2X1, P2X3, and Heteromeric P2X2/3 Receptors", MOLECULAR PHARMACOLOGY, vol. 53, no. 6, June 1998 (1998-06-01), pages 969 - 973, XP002919965 * |
Also Published As
Publication number | Publication date |
---|---|
EP1180141A2 (en) | 2002-02-20 |
CA2370659A1 (en) | 2000-10-26 |
WO2000063379A2 (en) | 2000-10-26 |
JP2004500021A (en) | 2004-01-08 |
MXPA01010646A (en) | 2002-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001079460A3 (en) | Polypeptides having haloperoxidase activity | |
WO2001079458A3 (en) | Polypeptides having haloperoxidase activity | |
WO1999003822A8 (en) | Bicyclic metabotropic glutamate receptor ligands | |
WO1999054286A3 (en) | Btk inhibitors and methods for their identification and use | |
WO2001079459A3 (en) | Polypeptides having haloperoxidase activity | |
CY2409B1 (en) | Substituted pyridines as selective cyclooxygenase-2 inhibitors. | |
ZA979585B (en) | Pesticidal methods, compositions and devices. | |
WO1999008649A3 (en) | Foaming skin cream | |
WO2004043082A3 (en) | Complementary beamforming methods and apparatuses | |
MXPA02002192A (en) | International trading system and method. | |
AU2401697A (en) | 4,1-benzoxazepines or 4,1-benzothiazepines and their use as squalene synthetase inhibitors | |
IL130102A (en) | Aminoguanidines and alkoxyguanidines as protease inhibitors, pharmaceutical compositions containing the same and processes for preparing the same | |
ZA9710187B (en) | Substituted nitrogen heterocycles, processes for their preparation and their use as pesticides. | |
WO2001036115A3 (en) | Cleaning process which uses ultrasonic waves | |
WO1998051348A3 (en) | Sustained-release delayed gels | |
AU2003295843A8 (en) | Mitoneet polypeptide from mitochondrial membranes, modulators thereof, and methods of using the same | |
ZA200005182B (en) | Substituted piperidines, method for their preparation and their use as pesticides and fungicides. | |
WO2002005643A3 (en) | Biocide compositions and methods and systems employing same | |
AU689345B2 (en) | Iminooxymethylene anilides, process and intermediate products for preparing the same and pesticides containing the same | |
AU2001236728A1 (en) | Implementation system for continuous welding, method, and products for implementation of the system and/or method | |
WO2000040232A3 (en) | Bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions | |
AU1875199A (en) | Safety system and device, as well as safety enhancing process appropriate therefor | |
WO2000063379A3 (en) | The p2x3 receptor, methods of altering p2x3 receptor activity and uses thereof | |
ZA9710242B (en) | Substituted Nitrogen Heterocycles, processes for their preparation and their use as pesticides. | |
WO1999010480A3 (en) | New tissue-specific calpaines, their production and their use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): CA JP MX |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
ENP | Entry into the national phase |
Ref document number: 2370659 Country of ref document: CA Ref country code: CA Ref document number: 2370659 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2001/010646 Country of ref document: MX |
|
ENP | Entry into the national phase |
Ref country code: JP Ref document number: 2000 612458 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000926289 Country of ref document: EP |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): CA JP MX |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
WWP | Wipo information: published in national office |
Ref document number: 2000926289 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000926289 Country of ref document: EP |